Skip to content
2000
Volume 24, Issue 1
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

Introduction

Mpox is a zoonotic disease caused by the Mpox virus, an Orthopoxvirus primarily infecting small mammals. Historically endemic to Central and West Africa, Mpox has emerged globally in recent years, likely linked to the cessation of smallpox vaccination programs. This review aims to provide a comprehensive synthesis of current knowledge on Mpox, focusing on its molecular biology, epidemiological trends, and therapeutic strategies to address recent global outbreaks.

Methods

The review integrates data from recent case studies, epidemiological reports, and clinical trials to examine the virus's genetic diversity, modes of transmission, and global spread. Additionally, it explores the efficacy and accessibility of vaccines and antiviral treatments, with particular attention to challenges in low-resource settings.

Results and Discussion

Analysis highlights the global Mpox outbreak from 2022 to 2023, during which 1,285 confirmed cases across 28 non-endemic countries were reported. This outbreak emphasizes the virus's capacity for global spread, its clinical manifestations, and the effectiveness of available treatment options. The review also identifies gaps in understanding Mpox’s genetic evolution and treatment scalability.

Conclusion

This review underscores the critical need for further research into Mpox's transmission mechanisms, genetic evolution, and therapeutic approaches. Addressing challenges related to vaccine distribution and antiviral access, particularly in low-resource settings, is essential for managing future outbreaks effectively.

Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525359513250414064134
2025-05-21
2026-03-09
Loading full text...

Full text loading...

References

  1. AdegboyeO.A. Eugenia CastellanosM. AleleF.O. PakA. EzechukwuH.C. HouK. EmetoT.I. Travel-related monkeypox outbreaks in the era of COVID-19 pandemic: Are we prepared?Viruses2022146128310.3390/v14061283 35746754
    [Google Scholar]
  2. KimH. AnD. LeeY. WooH. An overview and future challenges of the WHO international classification of disease ICD-11.J. Health Inform. Stat.202247424124910.21032/jhis.2022.47.4.241
    [Google Scholar]
  3. León-FigueroaD.A. Bonilla-AldanaD.K. PacharM. RomaníL. Saldaña-CumpaH.M. Anchay-ZuloetaC. Diaz-TorresM. Franco-ParedesC. SuárezJ.A. RamirezJ.D. Paniz-MondolfiA. Rodriguez-MoralesA.J. The never-ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond.Travel Med. Infect. Dis.20224910236210.1016/j.tmaid.2022.102362 35643256
    [Google Scholar]
  4. von MagnusP. A pox-like disease in cynomolgus monkeys.Acta Pathol. Microbiol. Scand.19594615617610.1111/j.1699‑0463.1959.tb00328.x
    [Google Scholar]
  5. LiH. ZhangH. DingK. WangX.H. SunG.Y. LiuZ.X. LuoY. The evolving epidemiology of monkeypox virus.Cytokine Growth Factor Rev.20226811210.1016/j.cytogfr.2022.10.002 36244878
    [Google Scholar]
  6. HappiC. AdetifaI. MbalaP. NjouomR. NakouneE. HappiA. NdodoN. AyansolaO. MboowaG. BedfordT. NeherR.A. RoemerC. HodcroftE. TegallyH. O’TooleÁ. RambautA. PybusO. KraemerM.U.G. WilkinsonE. IsidroJ. BorgesV. PintoM. GomesJ.P. FreitasL. ResendeP.C. LeeR.T.C. Maurer-StrohS. BaxterC. LessellsR. OgwellA.E. KebedeY. TessemaS.K. de OliveiraT. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus.PLoS Biol.2022208e300176910.1371/journal.pbio.3001769 35998195
    [Google Scholar]
  7. ReedK.D. MelskiJ.W. GrahamM.B. RegneryR.L. SotirM.J. WegnerM.V. KazmierczakJ.J. StratmanE.J. LiY. FairleyJ.A. SwainG.R. OlsonV.A. SargentE.K. KehlS.C. FraceM.A. KlineR. FoldyS.L. DavisJ.P. DamonI.K. The detection of monkeypox in humans in the Western hemisphere.N. Engl. J. Med.2004350434235010.1056/NEJMoa032299 14736926
    [Google Scholar]
  8. HughesA.L. IrausquinS. FriedmanR. The evolutionary biology of poxviruses.Infect. Genet. Evol.2010101505910.1016/j.meegid.2009.10.001 19833230
    [Google Scholar]
  9. McCollumA.M. DamonI.K. Human monkeypox.Clin. Infect. Dis.201458226026710.1093/cid/cit703 24158414
    [Google Scholar]
  10. ReynoldsM.G. DamonI.K. Outbreaks of human monkeypox after cessation of smallpox vaccination.Trends Microbiol.2012202808710.1016/j.tim.2011.12.001 22239910
    [Google Scholar]
  11. HammarlundE. LewisM.W. HansenS.G. StrelowL.I. NelsonJ.A. SextonG.J. HanifinJ.M. SlifkaM.K. Duration of antiviral immunity after smallpox vaccination.Nat. Med.2003991131113710.1038/nm917 12925846
    [Google Scholar]
  12. HudsonP.N. SelfJ. WeissS. BradenZ. XiaoY. GirgisN.M. EmersonG. HughesC. SammonsS.A. IsaacsS.N. DamonI.K. OlsonV.A. Elucidating the role of the complement control protein in monkeypox pathogenicity.PLoS One201274e3508610.1371/journal.pone.0035086 22496894
    [Google Scholar]
  13. HammarlundE. DasguptaA. PinillaC. NororiP. FrühK. SlifkaM.K. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation.Proc. Natl. Acad. Sci. USA200810538145671457210.1073/pnas.0800589105 18796610
    [Google Scholar]
  14. HraibM. JouniS. AlbitarM.M. AlaidiS. AlshehabiZ. The outbreak of monkeypox 2022: An overview.Ann. Med. Surg.20227910406910.1016/j.amsu.2022.104069 35860140
    [Google Scholar]
  15. FahrniM.L. Priyanka SharmaA. ChoudharyO.P. Monkeypox: Prioritizing public health through early intervention and treatment.Int. J. Surg.202210410677410.1016/j.ijsu.2022.106774 35863624
    [Google Scholar]
  16. FahrniM.L. Priyanka ChoudharyO.P. Possibility of vertical transmission of the human monkeypox virus.Int. J. Surg.202210510683210.1016/j.ijsu.2022.106832 35963577
    [Google Scholar]
  17. QuarleriJ. DelpinoM.V. GalvanV. Monkeypox: Considerations for the understanding and containment of the current outbreak in non-endemic countries.Geroscience20224442095210310.1007/s11357‑022‑00611‑6 35726117
    [Google Scholar]
  18. SeangS. BurrelS. TodescoE. LeducqV. MonselG. Le PluartD. CordevantC. PourcherV. PalichR. Evidence of human-to-dog transmission of monkeypox virus.Lancet20224001035365865910.1016/S0140‑6736(22)01487‑8 35963267
    [Google Scholar]
  19. MbalaP.K. HugginsJ.W. Riu-RoviraT. AhukaS.M. MulembakaniP. RimoinA.W. MartinJ.W. MuyembeJ.J.T. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo.J. Infect. Dis.2017216782482810.1093/infdis/jix260 29029147
    [Google Scholar]
  20. De BaetselierI. Van DijckC. KenyonC. CoppensJ. MichielsJ. de BlockT. SmetH. CoppensS. VanroyeF. BugertJ.J. GirlP. ZangeS. LiesenborghsL. BrosiusI. van GriensvenJ. SelhorstP. FlorenceE. Van den BosscheD. AriënK.K. RezendeA.M. VercauterenK. Van EsbroeckM. RamadanK. PlatteauT. Van LooverenK. BaeyensJ. Van HoyweghenC. MangelschotsM. HeyndrickxL. HaunerA. WillemsB. BottieauE. SoentjensP. BerensN. Van HentenS. BrackeS. VanbaelenT. VandenhoveL. VerschuerenJ. AriënK.K. LagaM. VanhamelJ. VuylstekeB. Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium.Nat. Med.202228112288229210.1038/s41591‑022‑02004‑w 35961373
    [Google Scholar]
  21. MusukaG. MoyoE. TungwararaN. MhangoM. PierreG. SarambaE. IradukundaP.G. DzinamariraT. A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: Lessons learned and evolving practices.IJID Regions20241210040210.1016/j.ijregi.2024.100402 39157420
    [Google Scholar]
  22. CevikM. The 2023 - 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World.Int. J. Infect. Dis.2024146107159
    [Google Scholar]
  23. CastroG.M. SiciliaP.E. WillingtonA. LópezL. PoklepovichT. CamposJ. BarbásM.G. Emergence of monkeypox virus in central Argentina: Epidemiological features and first complete genome sequences in the country.Rev. Argent. Microbiol.202456327628010.1016/j.ram.2024.05.003 39034190
    [Google Scholar]
  24. SobeyR. Massachusetts confirms rare monkeypox case, the first in the US this year.2022Available from: https://abcnews.go.com/Health/massachusetts-man-tests-positive-monkeypox/story?id=84817514
  25. News Wires. France, Germany, Belgium report first monkeypox cases amid unusual spread in Europe. France 24,Available from: https://www.france24.com/en/europe/20220520-france-germany-belgium-report-first-monkeypox-cases-amid-unusual-spread-in-europe 2022
  26. MillerM.J. Cash-GoldwasserS. MarxG.E. SchrodtC.A. KimballA. PadgettK. NoeR.S. McCormickD.W. WongJ.M. LabudaS.M. BorahB.F. ZuluI. GrantJ. DykeT.L. ManoharA. PragasamS.K. DavidsonJ.A. DavidoB. WalkeH.T. McCollumA.M. RaoA.K. YuY. McQuistonJ. MorrisS.B. MinhajF.S. Severe monkeypox in hospitalized patients-United States, August 10–October 10, 2022. MMWR Morb. Mortal Wkly Rep.202271441412141710.15585/mmwr.mm7144e1
    [Google Scholar]
  27. Centers for disease control and prevention. Ongoing 2022 Global Outbreak Cases and Data.Available from: https://archive.cdc.gov/www_cdc_gov/poxvirus/mpox/response/2022/world-map.html 2022
  28. Martín-IguacelR. PericasC. BrugueraA. RosellG. MartínezE. DíazY. AlonsoL. NomahD.K. BlancoJ.L. DomingoP. Álvarez-LópezP. LinaresM.S. Vilades LabordaC. MeraA. Calzado IsbertS. JohansenI.S. MiróJ.M. CasabonaJ. LlibreJ.M. Mpox: clinical outcomes and impact of vaccination in people with and without HIV: A population-wide study.Microorganisms20231111270110.3390/microorganisms11112701 38004713
    [Google Scholar]
  29. Centers for Disease Control and Prevention. Monkeypox in the United States and Around the World: Current Situation. Atlanta, GA, USA; Accessed August 29, https://www.cdc.gov/mpox/situation-summary/index.html 2025
  30. ThornhillJ.P. BarkatiS. WalmsleyS. RockstrohJ. AntinoriA. HarrisonL.B. PalichR. NoriA. ReevesI. HabibiM.S. ApeaV. BoeseckeC. VandekerckhoveL. YakubovskyM. SendagortaE. BlancoJ.L. FlorenceE. MoscheseD. MaltezF.M. GoorhuisA. PourcherV. MigaudP. NoeS. PintadoC. MaggiF. HansenA.B.E. HoffmannC. LezamaJ.I. MussiniC. CattelanA. MakofaneK. TanD. NozzaS. NemethJ. KleinM.B. OrkinC.M. Monkeypox virus infection in humans across 16 countries—April–June 2022.N. Engl. J. Med.2022387867969110.1056/NEJMoa2207323 35866746
    [Google Scholar]
  31. Rodriguez-NavaG. KadlecikP. FilardoT.D. AinD.L. CooperJ.D. McCormickD.W. WebberB.J. O’LaughlinK. PetersenB.W. NarasimhanS. SahniH.K. Myocarditis attributable to monkeypox virus infection in 2 patients, United States, 2022.Emerg. Infect. Dis.202228122508251210.3201/eid2812.221276 36179413
    [Google Scholar]
  32. CicesA. PrasadS. AkselradM. SellsN. WoodsK. SilverbergN.B. CaminsB. Mpox update: Clinical presentation, vaccination guidance, and management.Cutis2023111419720210.12788/cutis.0745 37289697
    [Google Scholar]
  33. AntinoriA. MazzottaV. VitaS. CarlettiF. TacconiD. LapiniL.E. D’AbramoA. CicaliniS. LapaD. PittalisS. PuroV. Rivano CapparucciaM. GiombiniE. GruberC.E.M. GarbugliaA.R. MaraniA. VairoF. GirardiE. VaiaF. NicastriE. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022.Euro Surveill.20222722220042110.2807/1560‑7917.ES.2022.27.22.2200421 35656836
    [Google Scholar]
  34. SaurinaG. ShiraziS. LaneJ.M. DanielB. DiEugeniaL. Myocarditis after smallpox vaccination: A case report.Clin. Infect. Dis.200337114514610.1086/377178 12830420
    [Google Scholar]
  35. TurnerM. MandiaJ. KeltnerC. HaynesR. FaestelP. MeaseL. Monkeypox in patient immunized with ACAM2000 smallpox vaccine during 2022 outbreak.Emerg. Infect. Dis.202228112336233810.3201/eid2811.221215 36104166
    [Google Scholar]
  36. Al JurdiA. KottonC.N. Monkeypox in transplant recipients: No breaks between outbreaks.Transplantation202210611e512e51310.1097/TP.0000000000004337 35973036
    [Google Scholar]
  37. ThakurN. Monkeypox2022tweets: A large-scale twitter dataset on the 2022 monkeypox outbreak, findings from analysis of tweets, and open research questions.Infect. Dis. Rep.202214685588310.3390/idr14060087 36412745
    [Google Scholar]
  38. HutsonC.L. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model.mSphere.202161e00126e0012110.1128/mSphere.00927‑20
    [Google Scholar]
  39. MalikS. MuhammadK. WaheedY. Nanotechnology: A revolution in modern industry.Molecules202328266110.3390/molecules28020661 36677717
    [Google Scholar]
  40. KurodaN. ShimizuT. HiranoD. IshikaneM. KataokaY. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review.J. Infect. Chemother.202329222823110.1016/j.jiac.2022.10.009 36283609
    [Google Scholar]
  41. McCarthyM.W. Therapeutic strategies to address monkeypox.Expert Rev. Anti Infect. Ther.202220101249125210.1080/14787210.2022.2113058 35953443
    [Google Scholar]
  42. AltindisM. PucaE. ShapoL. Diagnosis of monkeypox virus – An overview.Travel Med. Infect. Dis.20225010245910.1016/j.tmaid.2022.102459 36109000
    [Google Scholar]
  43. SeeK.C. Vaccination for monkeypox virus infection in humans: A review of key considerations.Vaccines (Basel)2022108134210.3390/vaccines10081342 36016230
    [Google Scholar]
  44. RamalingamK. AmaechiB.T. Phytochemicals: Their therapeutic potential against dental caries. Computational techniques for dental image analysis.IGI Global.201923827510.4018/978‑1‑5225‑6243‑6.ch011
    [Google Scholar]
  45. World Health Organization. WHO Director-General declares mpox outbreak a public health emergency of international concern. World Health Organization,2024Available from: https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern
/content/journals/aia/10.2174/0122113525359513250414064134
Loading
/content/journals/aia/10.2174/0122113525359513250414064134
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): chordopoxvirinae; congo basin; Mpox; orthopoxvirus; poxviridae; zoonotic disease
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test